STERIS increased its fiscal 2027 capital expenditure outlook to reflect the $600 million North Carolina chemistry campus investment. Fiscal Q1 free cash flow declined 14.4% year over year because of a smaller working-capital contribution despite higher net income. The company slightly lowered its free cash flow expectations while maintaining its fiscal 2027 revenue and adjusted EPS guidance.
Key facts
The company increased capital expenditures projections and slightly lowered free cash flow expectations to reflect the new North Carolina investment. source
Free cash flow declined by 14.4% in fiscal Q1 2027 due to a smaller working capital contribution despite higher net income. source